iVision Tech S.p.A (IVN) Fair Value & Analysis
Consumer Cyclical · IT · Market cap €13.7M
Fair value as of: Aug 8, 2026
From 14 valuation models · updated today
Fair value updated Aug 8, 2026, revised from €0.1600 to €0.1500 (−6.3%) since Jul 3, 2026. Share price −24.8% over the past month.
Below-average quality, and screening another 88% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (€0.2000). The favourable scenario is already priced in.
- Weak quality (27/100) and above fair value at the same time, the margin of safety is missing on both counts.
- A fairly wide model range (€0.1100 to €0.2000) leaves room in how you read the outcome.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 8, 2026.
How to read this chart
36‑month range €0.7400 – €2.68 · fair‑value band €0.1100 – €0.2000 · the €1.29 price screens above the €0.1500 fair value. Dashed = 300-day average. As of Aug 8, 2026.
Analysis
iVision Tech S.p.A (IVN) currently trades at €1.29, while our model-based Fair Value estimate is €0.1500, implying the stock looks roughly 88.4% overvalued today. We read business quality at 27/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Trailing-twelve-month revenue stands at €20.4M. Revenue declined 9.1% year over year. It earns a return on equity of 0.3%. Net debt stands at €8.6M. Fundamentals as of Aug 8, 2026
Our scenario range runs from €0.1100 (bear case) to €0.2000 (bull case); at €1.29, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 55% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 0% fair-value upside, at -88%, IVN screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 14 models by family
Widest divergence: Asset-Based (€0.8500) versus Multiples (€0.0700). Highest evidence: ROIC Compounder (72).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 8, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 39 · Market factors (momentum, volatility) 13
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
iVision Tech S.p.A. designs and produces acetate eyeglass frames and sunglasses, and combination glasses in Italy. The company was incorporated in 2020 and is headquartered in Milan, Italy. iVision Tech S.p.A. operates as a subsidiary of Effe Group S.R.L.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
iVision Tech S.p.A reported revenue of €19.3M in FY2025 versus €4.5M in FY2021, a compound +43.8%/yr. Reported net income was €28.5K in FY2025, compounding −22.0%/yr from FY2021.
IVN screens 88% overvalued. Compare with NIKE, Inc →
Peer Group
Footwear & Accessories · 95 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Footwear & Accessories median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Footwear & Accessories stocks, each showing price versus our Fair Value estimate (as of Aug 8, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| NIKE, Inc NKE | $44.37 | $35.63 | -20% |
| adidas AG 1ADS | €165.00 | €65.71 | -60% |
| Deckers Outdoor Corporation DECK | $106.49 | $125.16 | +18% |
| On Holding ONON | $38.20 | $17.64 | -54% |
| Zhejiang China Commodities City Group 600415 | ¥11.59 | ¥13.03 | +12% |
| Birkenstock Holding BIRK | $44.36 | $44.14 | -0% |
| Crocs, Inc CROX | $138.91 | $203.65 | +47% |
| Huali Industrial Group 300979 | ¥31.10 | ¥54.71 | +76% |
| PUMA SE PUM | €29.31 | €10.57 | -64% |
| Steven Madden, Ltd SHOO | $43.26 | $11.69 | -73% |
Compare iVision Tech S.p.A with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is iVision Tech S.p.A (IVN) overvalued or undervalued?
What is the fair value of IVN?
What is the quality score of IVN?
What is the revenue of iVision Tech S.p.A (IVN)?
What is the net profit margin of IVN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track iVision Tech S.p.A and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.